Everforth Inc annual report, Q4 FY2007

Business Context and Reporting Period

Company: On Assignment, Inc. (Note: Input metadata referenced "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2007
Business Overview: A diversified professional staffing firm operating in four segments: Life Sciences, Healthcare, Physician (VISTA), and IT and Engineering (Oxford). The company provides flexible and permanent staffing solutions for specialty skills including laboratory/scientific, healthcare/nursing/physician, medical financial, information technology, and engineering.

Key Financial Metrics

Metric 2007 2006
Total Revenues $567,180,000 $287,566,000
Gross Profit $179,537,000 $77,841,000
Gross Margin 31.7% 27.1%
Operating Income $27,595,000 $9,941,000
Net Income $9,322,000 $11,044,000
Diluted EPS $0.26 $0.39
Cash and Cash Equivalents $37,764,000 $105,483,000
Working Capital $79,009,000 $135,501,000
Long-Term Debt $135,913,000 $0
Goodwill $193,552,000 $17,109,000

Material Changes vs. Prior Period

  • Revenue Growth: Consolidated revenues increased 97.2% to $567.2 million. This growth was primarily driven by the acquisitions of VISTA Staffing Solutions (Physician segment) and Oxford Global Resources (IT and Engineering segment), which contributed $257.5 million of the increase.
  • Segment Performance:
    • Life Sciences: Revenue increased 14.6% to $134.6 million; Gross margin improved 90 basis points to 33.4%.
    • Healthcare: Revenue increased 2.9% to $175.1 million; Gross margin improved 200 basis points to 25.3%.
    • Physician (New): Generated $74.6 million in revenue (13.2% of total) with a 29.2% gross margin.
    • IT and Engineering (New): Generated $182.9 million in revenue (32.2% of total) with a 37.4% gross margin.
  • Expenses: Selling, General, and Administrative (SG&A) expenses increased 123.8% to $151.9 million, largely due to the inclusion of acquired entities and increased amortization of intangible assets ($15.3 million in 2007 vs. $0.96 million in 2006).
  • Debt: The company incurred significant debt in 2007 to finance acquisitions, entering a $165 million senior secured credit facility. Interest expense rose from $54,000 in 2006 to $10.97 million in 2007.
  • Net Income: Despite a 130.6% increase in gross profit, net income decreased 15.6% to $9.3 million due to higher interest expenses, increased amortization, and a higher effective tax rate (44.6% in 2007 vs. 4.7% in 2006, the latter benefiting from a valuation allowance reversal).

Guidance, Outlook, Risks, and Unusual Items

  • Outlook: Management expects to continue growing revenues and improving gross profit while rationalizing SG&A expenses. The company plans to leverage synergies between legacy businesses and new acquisitions (VISTA and Oxford).
  • Unusual Items:
    • Acquisitions: The 2007 results are significantly impacted by the January 2007 acquisitions of VISTA and Oxford. Pro-forma results suggest operating income would have been $28.1 million in 2007.
    • Interest Rate Swap: The company recorded a $1.2 million loss on the change in fair value of an interest rate swap used to hedge a portion of its debt.
    • Tax Provision: The 2006 effective tax rate was anomalously low due to a $4.9 million reversal of a valuation allowance. The 2007 rate of 44.6% reflects a return to normalcy.
  • Risks:
    • Client Concentration: While no single client exceeded 2.9% of total revenue in 2007, the top 10 clients in the Nurse Travel line accounted for 28.6% of that segment's revenue.
    • Integration Risk: Risks associated with integrating VISTA and Oxford, including potential attrition of key personnel and failure to realize synergies.
    • Independent Contractor Classification: The company classifies locum tenens physicians as independent contractors. Reclassification by tax authorities could materially impact the business model and result in significant retroactive liabilities.
    • Goodwill Impairment: The company holds $193.6 million in goodwill. Future impairment charges could negatively impact operating results.

Investor Verification Checklist

  • Debt Covenants: Verify compliance with the $165 million credit facility covenants, specifically the minimum total leverage ratio and interest coverage ratio.
  • Acquisition Earn-outs: Monitor the payment of accrued earn-outs ($8.5 million total for 2007 performance) and potential additional consideration ($11.5 million) contingent on 2008 performance for VISTA and Oxford.
  • Client Concentration: Assess the stability of the top 10 Nurse Travel clients, which represent a significant portion of that segment's revenue.
  • Goodwill Valuation: Review the annual goodwill impairment testing methodology, given the substantial increase in goodwill from acquisitions.
  • Legal Proceedings: Track the status of the lawsuit against former Oxford employees and Black Diamond Networks regarding non-compete and confidentiality breaches, as legal fees may be significant.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.